Literature DB >> 10980953

Pediatric inflammatory bowel disease.

S R Orenstein1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980953     DOI: 10.1007/s11894-999-0038-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


× No keyword cloud information.
  5 in total

1.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

Authors:  F M Ruemmele; S R Targan; G Levy; M Dubinsky; J Braun; E G Seidman
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

2.  Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

Authors:  Y Bouhnik; M Lémann; J Y Mary; G Scemama; R Taï; C Matuchansky; R Modigliani; J C Rambaud
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

3.  Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.

Authors:  J Markowitz; K Grancher; F Mandel; F Daum
Journal:  Am J Gastroenterol       Date:  1993-01       Impact factor: 10.864

4.  The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.

Authors:  H A Liebman; N Kashani; D Sutherland; W McGehee; A L Kam
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

5.  Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.

Authors:  B S Kirschner
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.